Contact the team

The GloMY Trial Team are always here to help. For further information about the GloMY trial please contact us:

General enquiries:

For general queries about the study, site set-up and queries about collection of data and data analysis please contact the Birmingham Clinical Trials Unit (BCTU):

Postal address:
GloMY Trial Office
Birmingham Clinical Trials Unit
Robert Aitken Institute
College of Medical and Dental Sciences
University of Birmingham
Edgbaston
Birmingham B15 2TT

Freepost address:
GloMY Trial Office
FREEPOST RRKR-JUZR-HZHG
Birmingham Clinical Trials Unit
Robert Aitken Institute
College of Medical and Dental Sciences
University of Birmingham
Birmingham B15 2TT

Fax:  +44 (0)121 415 9135

Email: glomy-trial@trials.bham.ac.uk

GloMY Trial Staff:

Elizabeth Brettell Renal Trials Manager, Tel: +44 (0)121 415 9130

Noreen Akhtar Renal Trials Administrator, Tel: +44 (0)121 415 9131

Emma Barsoum Renal Trial Administrator, Tel: +44 (0)121 415 9133

Gemma Ryan, Data Manager, Tel: +44 (0)121 415 9134

Charmaine Meek, Data Manager, Tel: +44 (0)121 415 9132

GloMY Trial Chief Investigator:

Professor Lorraine Harper
University Hospitals Birmingham NHS Foundation Trust
United Kingdom
Tel: +44 (0)121 371 3238.

Data Entry

Internet: https://www.trials.bham.ac.uk/GloMY (available 24hrs)

The GloMY randomisation closed on 21st Aug 2012  

Find out more information about our other renal trials

BCTU
The University of Birmingham Clinical Trials Unit (BCTU) is a Research Unit in the School of Medicine specialising in the design, conduct and analysis of clinical trials.

eGFR-C
Accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease: prospective longitudinal study in a multi-ethnic population.

PEXIVAS
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: an international randomised controlled trial.

PREDNOS
Long-term tapering versus standard prednisolone (steroid) therapy for the treatment of the initial episode of childhood nephrotic syndrome: national multicentre randomised double blind trial

PREDNOS 2
Short course daily prednisolone therapy at the time of upper respiratory tract infection in children with relapsing steroid sensitive nephrotic syndrome.

STOP-ACEi
STOP-ACEi is a multi-centre, randomised controlled trial of Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) withdrawal in advanced kidney disease.